Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA071921-04
Application #
6254699
Study Section
Subcommittee G - Education (NCI)
Program Officer
Xie, Heng
Project Start
1997-05-01
Project End
2003-02-28
Budget Start
2001-05-03
Budget End
2002-02-28
Support Year
4
Fiscal Year
2001
Total Cost
$456,329
Indirect Cost

  Institution

Name
University of Southern California
Department
Pathology
Type
Schools of Medicine
DUNS #
041544081
City
Los Angeles
State
CA
Country
United States
Zip Code
90089

  Publications

Bartsch Jr, Georg; Mitra, Anirban P; Mitra, Sheetal A et al. (2016) Use of Artificial Intelligence and Machine Learning Algorithms with Gene Expression Profiling to Predict Recurrent Nonmuscle Invasive Urothelial Carcinoma of the Bladder. J Urol 195:493-8
Mata, Douglas A; Groshen, Susan; Von Rundstedt, Friedrich-Carl et al. (2015) Variability in surgical quality in a phase III clinical trial of radical cystectomy in patients with organ-confined, node-negative urothelial carcinoma of the bladder. J Surg Oncol 111:923-8
von Rundstedt, Friedrich-Carl; Mata, Douglas A; Groshen, Susan et al. (2015) Significance of lymphovascular invasion in organ-confined, node-negative urothelial cancer of the bladder: data from the prospective p53-MVAC trial. BJU Int 116:44-9
Mitra, Anirban P; Castelao, Jose E; Hawes, Debra et al. (2013) Combination of molecular alterations and smoking intensity predicts bladder cancer outcome: a report from the Los Angeles Cancer Surveillance Program. Cancer 119:756-65
Mitra, Anirban P; Hansel, Donna E; Cote, Richard J (2012) Prognostic value of cell-cycle regulation biomarkers in bladder cancer. Semin Oncol 39:524-33
Stadler, Walter M; Lerner, Seth P; Groshen, Susan et al. (2011) Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status. J Clin Oncol 29:3443-9
Bartsch, Georg; Mitra, Anirban P; Cote, Richard J (2010) Expression profiling for bladder cancer: strategies to uncover prognostic factors. Expert Rev Anticancer Ther 10:1945-54
Mitra, Anirban P; Cote, Richard J (2009) Molecular pathogenesis and diagnostics of bladder cancer. Annu Rev Pathol 4:251-85
Lerner, Seth P; Tangen, Catherine M; Sucharew, Heidi et al. (2009) Failure to achieve a complete response to induction BCG therapy is associated with increased risk of disease worsening and death in patients with high risk non-muscle invasive bladder cancer. Urol Oncol 27:155-9
Mitra, Anirban P; Birkhahn, Marc; Cote, Richard J (2009) Re: Joseph Chin. In Search of the Perfect Crystal Ball for Ta Urothelial Cancer. Eur Urol. doi:10.1016/j.eururo.2009.09.014. Eur Urol 57:23-24

Showing the most recent 10 out of 18 publications